Nature's Health receives warning
This article was originally published in The Tan Sheet
FDA warns Nature's Health Co. that at least 18 of its products marketed as supplements are unapproved drugs due to unlawful disease treatment and prevention claims that "were too numerous to list." It also warns the Salt Lake City firm that several of the products, including Cardiac Balance I to control arrhythmia and Flavescent for autoimmune system disease symptom relief, are misbranded because they are offered for conditions that are not self-diagnosable or self-treatable. According to the Sept. 21 letter, the products advertised at 1www.nature-s-health.com were not recognized as safe and effective and, therefore, are new drugs
You may also be interested in...
Pfizer has pressed on with the launch of a fourth biosimilar pegfilgrastim product, Nyvepria (pegfilgrastim-apgf), according to an investment bank. With Amgen continuing to hold more than 70% of the market, there is opportunity for Pfizer to capture significant market share.
EU Business Round-Up: Galenica Boosted By Deals, Alliance's Sales Rise, And Beiersdorf Relaunches Wound Care
Latest EU business news: Galenica posts sales up in 2020 thanks to deals; Alliance Pharma's Consumer sales edge up despite COVID-19; and Beiersdorf is relaunching its wound care range with sustainability in mind.
As it gears up to begin production at its new clinical and commercial manufacturing site in Warsaw, Polpharma Biologics has announced a new logo and corporate message to mark a year of “significant growth.”